Nexalin Technology, Inc. (NXLIW)
USD 0.19
(42.69%)
USD 0.19
(42.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4463.00 USD | -99.41% |
| 2022 | 755.26 Thousand USD | -11.15% |
| 2021 | 850.05 Thousand USD | 17.08% |
| 2020 | 726.01 Thousand USD | -13.28% |
| 2019 | 837.22 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - USD | -100.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 FY | 4463.00 USD | -99.41% |
| 2023 Q2 | 530.48 Thousand USD | -2.31% |
| 2023 Q3 | 517.63 Thousand USD | -2.42% |
| 2023 Q1 | 543.02 Thousand USD | -28.1% |
| 2023 Q4 | 4463.00 USD | -99.14% |
| 2022 Q2 | 806.04 Thousand USD | -4.65% |
| 2022 FY | 755.26 Thousand USD | -11.15% |
| 2022 Q1 | 845.32 Thousand USD | -0.56% |
| 2022 Q4 | 755.26 Thousand USD | -1.56% |
| 2022 Q3 | 767.19 Thousand USD | -4.82% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 850.05 Thousand USD | 17.08% |
| 2021 Q4 | 850.05 Thousand USD | 27.9% |
| 2021 Q3 | 664.64 Thousand USD | -4.63% |
| 2021 Q2 | 696.91 Thousand USD | 0.0% |
| 2020 Q4 | 689.03 Thousand USD | 0.0% |
| 2020 FY | 726.01 Thousand USD | -13.28% |
| 2019 FY | 837.22 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AdaptHealth Corp. | 2.29 Billion USD | 100.0% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 99.985% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 99.989% |
| BrainsWay Ltd. | 471 Thousand USD | 99.052% |
| Cerus Corporation | 95.99 Million USD | 99.995% |
| CVRx, Inc. | 30.61 Million USD | 99.985% |
| electroCore, Inc. | 626 Thousand USD | 99.287% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | 99.569% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | 97.58% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | 92.17% |
| Orthofix Medical Inc. | 134.19 Million USD | 99.997% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 99.994% |
| iCAD, Inc. | 461 Thousand USD | 99.032% |
| IceCure Medical Ltd | 599 Thousand USD | 99.255% |
| 908 Devices Inc. | 5.94 Million USD | 99.925% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 99.81% |
| Movano Inc. | 252 Thousand USD | 98.229% |
| MaxCyte, Inc. | 18.74 Million USD | 99.976% |
| PAVmed Inc | 48.72 Million USD | 99.991% |
| Insulet Corporation | 1.44 Billion USD | 100.0% |
| Quanterix Corporation | 41.46 Million USD | 99.989% |
| RxSight, Inc. | 3.01 Million USD | 99.852% |
| Sight Sciences, Inc. | 35.41 Million USD | 99.987% |
| Sintx Technologies, Inc. | 4.24 Million USD | 99.895% |
| Surmodics, Inc. | 29.4 Million USD | 99.985% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | 99.72% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | 99.776% |
| Venus Concept Inc. | 79.69 Million USD | 99.994% |
| NeuroPace, Inc. | 72.39 Million USD | 99.994% |
| LENSAR, Inc. | 2.3 Million USD | 99.807% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 99.939% |
| SI-BONE, Inc. | 38.99 Million USD | 99.989% |
| TELA Bio, Inc. | 42.78 Million USD | 99.99% |
| Tivic Health Systems, Inc. | 369 Thousand USD | 98.791% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 99.971% |
| LivaNova PLC | 640.4 Million USD | 99.999% |
| Bioventus Inc. | 409.47 Million USD | 99.999% |
| Envoy Medical, Inc. | 404 Thousand USD | 98.895% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 99.987% |
| Spectral AI, Inc. | 1.28 Million USD | 99.654% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 99.947% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | 99.525% |
| Inogen, Inc. | 21.92 Million USD | 99.98% |
| OrthoPediatrics Corp. | 23.76 Million USD | 99.981% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.999% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | 99.776% |
| Apyx Medical Corporation | 38.5 Million USD | 99.988% |
| Cutera, Inc. | 431.91 Million USD | 99.999% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 99.971% |
| BioSig Technologies, Inc. | 452 Thousand USD | 99.013% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 99.968% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 100.0% |
| Axonics, Inc. | 27.61 Million USD | 99.984% |
| Outset Medical, Inc. | 136.18 Million USD | 99.997% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | 99.093% |
| IRIDEX Corporation | 2.74 Million USD | 99.837% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 99.994% |
| IRadimed Corporation | 2.04 Million USD | 99.782% |
| INVO Bioscience, Inc. | 8.68 Million USD | 99.949% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 99.957% |
| Varex Imaging Corporation | 469.5 Million USD | 99.999% |
| Quipt Home Medical Corp. | 98.94 Million USD | 99.995% |
| BIOLASE, Inc. | 17.91 Million USD | 99.975% |
| Beyond Air, Inc. | 17.83 Million USD | 99.975% |
| Pulmonx Corporation | 41.42 Million USD | 99.989% |
| Modular Medical, Inc. | 1.19 Million USD | 99.625% |
| ReShape Lifesciences Inc. | 262 Thousand USD | 98.297% |
| FONAR Corporation | 41.67 Million USD | 99.989% |
| Semler Scientific, Inc. | 70 Thousand USD | 93.624% |
| InMode Ltd. | 9.01 Million USD | 99.951% |
| Bruker Corporation | 1.37 Billion USD | 100.0% |
| Cytosorbents Corporation | 18.31 Million USD | 99.976% |
| DexCom, Inc. | 2.59 Billion USD | 100.0% |
| Align Technology, Inc. | 96.96 Million USD | 99.995% |
| ZimVie Inc. | 521.92 Million USD | 99.999% |
| Nexalin Technology, Inc. | 4463.00 USD | 0.0% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 99.776% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.999% |
| Profound Medical Corp. | 7.9 Million USD | 99.944% |
| Vivani Medical, Inc. | 20.69 Million USD | 99.978% |
| enVVeno Medical Corporation | 1.4 Million USD | 99.682% |
| Inari Medical, Inc. | 32.04 Million USD | 99.986% |
| UFP Technologies, Inc. | 46.03 Million USD | 99.99% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 99.855% |
| Nuwellis, Inc. | 981 Thousand USD | 99.545% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 99.997% |
| InspireMD, Inc. | 1.59 Million USD | 99.72% |
| PAVmed Inc. | 48.72 Million USD | 99.991% |
| AxoGen, Inc. | 69.29 Million USD | 99.994% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 99.991% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 99.851% |
| Tenon Medical, Inc. | 1.17 Million USD | 99.62% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 99.555% |
| NanoVibronix, Inc. | 5000.00 USD | 10.74% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 99.81% |
| Sensus Healthcare, Inc. | 783 Thousand USD | 99.43% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 100.0% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.999% |
| ReWalk Robotics Ltd. | 1.9 Million USD | 99.765% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | 98.147% |
| Hyperfine, Inc. | 185 Thousand USD | 97.588% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 99.998% |
| Biomerica, Inc. | 785 Thousand USD | 99.431% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 99.007% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | 98.794% |
| Silk Road Medical, Inc | 84.63 Million USD | 99.995% |